These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 22324989

  • 1. Does HPV type 16 or 18 prevalence in cervical intraepithelial neoplasia grade 3 lesions vary by age? An important issue for postvaccination surveillance.
    Brotherton JM, Tabrizi SN, Garland SM.
    Future Microbiol; 2012 Feb; 7(2):193-9. PubMed ID: 22324989
    [Abstract] [Full Text] [Related]

  • 2. Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of three cohorts from randomized trials.
    Lehtinen M, Lagheden C, Luostarinen T, Eriksson T, Apter D, Harjula K, Kuortti M, Natunen K, Palmroth J, Petäjä T, Pukkala E, Siitari-Mattila M, Struyf F, Nieminen P, Paavonen J, Dubin G, Dillner J.
    BMJ Open; 2017 Aug 18; 7(8):e015867. PubMed ID: 28821519
    [Abstract] [Full Text] [Related]

  • 3. Clinical relevance of partial HPV16/18 genotyping in stratifying HPV-positive women attending routine cervical cancer screening: a population-based cohort study.
    Gori S, Battagello J, Gustinucci D, Campari C, Zorzi M, Frayle H, Passamonti B, Sartori G, Bulletti S, Fodero C, Cesarini E, Faggiano R, Del Mistro A.
    BJOG; 2021 Jul 18; 128(8):1353-1362. PubMed ID: 33326680
    [Abstract] [Full Text] [Related]

  • 4. Pre-vaccination type-specific HPV prevalence in confirmed cervical high grade lesions in the Māori and non-Māori populations in New Zealand.
    Kang YJ, Lewis H, Smith MA, Simonella L, Neal H, Bromhead C, Canfell K.
    BMC Infect Dis; 2015 Aug 22; 15():365. PubMed ID: 26297490
    [Abstract] [Full Text] [Related]

  • 5. Human papillomavirus in invasive cervical cancer and cervical intraepithelial neoplasia 2 and 3 in Venezuela: a cross-sectional study.
    Sánchez-Lander J, Cortiñas P, Loureiro CL, Pujol FH, Medina F, Capote-Negrín L, Bianchi G, García-Barriola V, Ruiz-Benni A, Avilán-Rovira J, Acosta H.
    Cancer Epidemiol; 2012 Oct 22; 36(5):e284-7. PubMed ID: 22608058
    [Abstract] [Full Text] [Related]

  • 6. Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U.S. screening population: data from the ATHENA trial.
    Monsonego J, Cox JT, Behrens C, Sandri M, Franco EL, Yap PS, Huh W.
    Gynecol Oncol; 2015 Apr 22; 137(1):47-54. PubMed ID: 25667973
    [Abstract] [Full Text] [Related]

  • 7. Prevalence of human papillomavirus types in high-grade cervical intraepithelial neoplasia and cancer in Italy.
    Carozzi FM, Tornesello ML, Burroni E, Loquercio G, Carillo G, Angeloni C, Scalisi A, Macis R, Chini F, Buonaguro FM, Giorgi Rossi P, HPV Prevalence Italian Working Group.
    Cancer Epidemiol Biomarkers Prev; 2010 Sep 22; 19(9):2389-400. PubMed ID: 20826836
    [Abstract] [Full Text] [Related]

  • 8. Cervical adenocarcinoma in situ: Human papillomavirus types and incidence trends in five states, 2008-2015.
    Cleveland AA, Gargano JW, Park IU, Griffin MR, Niccolai LM, Powell M, Bennett NM, Saadeh K, Pemmaraju M, Higgins K, Ehlers S, Scahill M, Johnson Jones ML, Querec T, Markowitz LE, Unger ER, HPV-IMPACT Working Group.
    Int J Cancer; 2020 Feb 01; 146(3):810-818. PubMed ID: 30980692
    [Abstract] [Full Text] [Related]

  • 9. Human papillomavirus infections among women with cervical lesions and cervical cancer in Eastern China: genotype-specific prevalence and attribution.
    Zhang L, Bi Q, Deng H, Xu J, Chen J, Zhang M, Mu X.
    BMC Infect Dis; 2017 Jan 31; 17(1):107. PubMed ID: 28143439
    [Abstract] [Full Text] [Related]

  • 10. HPV16/18 prevalence in high-grade cervical lesions in an Australian population offered catch-up HPV vaccination.
    Cornall AM, Saville M, Pyman J, Callegari ET, Tan FH, Brotherton JML, Malloy MJ, Tabrizi SN, Wrede CD, Garland SM, VACCINE Study Group.
    Vaccine; 2020 Sep 11; 38(40):6304-6311. PubMed ID: 32736938
    [Abstract] [Full Text] [Related]

  • 11. Type-specific oncogenic human papillomavirus infection in high grade cervical disease in New Zealand.
    Simonella LM, Lewis H, Smith M, Neal H, Bromhead C, Canfell K.
    BMC Infect Dis; 2013 Mar 03; 13():114. PubMed ID: 23452957
    [Abstract] [Full Text] [Related]

  • 12. HPV16 is associated with younger age in women with cervical intraepithelial neoplasia grade 2 and 3.
    Baandrup L, Munk C, Andersen KK, Junge J, Iftner T, Kjær SK.
    Gynecol Oncol; 2012 Feb 03; 124(2):281-5. PubMed ID: 22036987
    [Abstract] [Full Text] [Related]

  • 13. Co-infections of HPV16/18 with other high-risk HPV types and the risk of cervical carcinogenesis: A large population-based study.
    Wu P, Xiong H, Yang M, Li L, Wu P, Lazare C, Cao C, Gao P, Meng Y, Zhi W, Lin S, Hu J, Wei J, Ma D, Liu J, Yin P, Xing H.
    Gynecol Oncol; 2019 Dec 03; 155(3):436-443. PubMed ID: 31604662
    [Abstract] [Full Text] [Related]

  • 14. HPV16 and HPV18 genotyping triage in young women with borderline cytology or mild dyskaryosis: effect of age on genotype-specific risk of high-grade CIN.
    McKenna M, McMenamin M, McDowell A.
    Cytopathology; 2016 Aug 03; 27(4):261-8. PubMed ID: 26873051
    [Abstract] [Full Text] [Related]

  • 15. Age-related distribution of uncommon HPV genotypes in cervical intraepithelial neoplasia grade 3.
    Giannella L, Giorgi Rossi P, Delli Carpini G, Di Giuseppe J, Bogani G, Gardella B, Monti E, Liverani CA, Ghelardi A, Insinga S, Raspagliesi F, Spinillo A, Vercellini P, Roncella E, Ciavattini A.
    Gynecol Oncol; 2021 Jun 03; 161(3):741-747. PubMed ID: 33795132
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of Human Papillomavirus Genotypes Among Women With High-Grade Cervical Lesions in Beijing, China.
    Xiao M, Xu Q, Li H, Gao H, Bie Y, Zhang Z.
    Medicine (Baltimore); 2016 Jan 03; 95(3):e2555. PubMed ID: 26817906
    [Abstract] [Full Text] [Related]

  • 17. Risk for high-grade cervical intraepithelial neoplasia associated with variants of human papillomavirus types 16 and 18.
    Xi LF, Koutsky LA, Hildesheim A, Galloway DA, Wheeler CM, Winer RL, Ho J, Kiviat NB.
    Cancer Epidemiol Biomarkers Prev; 2007 Jan 03; 16(1):4-10. PubMed ID: 17220325
    [Abstract] [Full Text] [Related]

  • 18. Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada.
    Coutlée F, Ratnam S, Ramanakumar AV, Insinga RR, Bentley J, Escott N, Ghatage P, Koushik A, Ferenczy A, Franco EL.
    J Med Virol; 2011 Jun 03; 83(6):1034-41. PubMed ID: 21503917
    [Abstract] [Full Text] [Related]

  • 19. Type-specific HPV prevalence in invasive cervical cancer in the UK prior to national HPV immunisation programme: baseline for monitoring the effects of immunisation.
    Mesher D, Cuschieri K, Hibbitts S, Jamison J, Sargent A, Pollock KG, Powell N, Wilson R, McCall F, Fiander A, Soldan K.
    J Clin Pathol; 2015 Feb 03; 68(2):135-40. PubMed ID: 25410654
    [Abstract] [Full Text] [Related]

  • 20. Assessment of the effectiveness of HPV16/18 infection referred for colposcopy in cervical cancer screening in Northwest of China.
    Zhang Q, Zhao M, Cao D, Wei X, Wang L, Li Y, Yang T, Zhao J, Pei M, Jia H, Cao S, Quan S, Yang X.
    J Med Virol; 2018 Jan 03; 90(1):165-171. PubMed ID: 28710863
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.